Moon Ju Jang

ORCID: 0000-0001-7440-7573
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Venous Thromboembolism Diagnosis and Management
  • Blood Coagulation and Thrombosis Mechanisms
  • Complement system in diseases
  • Platelet Disorders and Treatments
  • Folate and B Vitamins Research
  • Blood groups and transfusion
  • Atrial Fibrillation Management and Outcomes
  • Cancer-related molecular mechanisms research
  • Hematopoietic Stem Cell Transplantation
  • MicroRNA in disease regulation
  • Estrogen and related hormone effects
  • Diagnosis and Treatment of Venous Diseases
  • Renal Diseases and Glomerulopathies
  • Hemoglobinopathies and Related Disorders
  • Angiogenesis and VEGF in Cancer
  • Circular RNAs in diseases
  • Central Venous Catheters and Hemodialysis
  • Viral-associated cancers and disorders
  • Sepsis Diagnosis and Treatment
  • Cardiac tumors and thrombi
  • Blood disorders and treatments
  • Acute Myocardial Infarction Research
  • Acute Lymphoblastic Leukemia research
  • Colorectal Cancer Treatments and Studies
  • Epigenetics and DNA Methylation

CHA University
2007-2018

CHA Bundang Medical Center
2013-2015

UiT The Arctic University of Norway
2014

University of Insubria
2009-2014

Centro Cardiologico Monzino
2014

Medical University of Vienna
2014

University of Vermont
2014

Federico II University Hospital
2014

Ca' Foncello Hospital
2014

Minnesota Department of Health
2014

10.1111/j.1538-7836.2010.04108.x article EN publisher-specific-oa Journal of Thrombosis and Haemostasis 2010-10-13

Abstract MicroRNAs (miRNAs) are small, 18‐ to 22‐nucleotide non‐coding RNAs that regulate target gene expression. Although recent studies focused on various diseases harbor the miR‐146a C>G (rs2910164), 149 C>T (rs2292832), 196a2 (rs11614913), and 499 A>G (rs3746444) polymorphisms, role of miRNA genetic variants in colorectal cancer is still unknown. The present study aimed evaluate four polymorphisms patients with cancer. We enrolled 446 502 control subjects from Korean population....

10.1002/mc.21849 article EN Molecular Carcinogenesis 2011-12-07

In 2010, we proposed the first Korean Guidelines for Prevention of Venous Thromboembolism (VTE).It was applicable to patients, by modifying contents second edition Japanese guidelines prevention VTE and 8th American College Chest Physicians (ACCP) evidence-based clinical practice guidelines.From 2007 2011, conducted a nationwide study regarding incidence after major surgery using Health Insurance Review Assessment Service (HIRA) database.In addition, have considered 9th ACCP Evidenced-Based...

10.3346/jkms.2014.29.2.164 article EN cc-by-nc Journal of Korean Medical Science 2014-01-01

The metabolic syndrome (MS) is a known risk factor for arterial thromboembolism. Preliminary reports have also suggested the association between MS and venous thromboembolism (VTE).In this case-control study, we investigated VTE in Korean patients. Patients with objectively diagnosed healthy control subjects underwent clinical assessment presence of according to National Cholesterol Education Adult Treatment Panel III criteria modified body mass index (WHO Asian Pacific Perspective, 2000)....

10.1161/atvbaha.109.184085 article EN Arteriosclerosis Thrombosis and Vascular Biology 2009-02-18

Immunomodulatory properties of mesenchymal stem cells (MSCs) have been applied to reduce the incidence graft-versus-host disease (GVHD) after hematopoietic cell transplantation (HSCT). Among various sources MSCs that immunomodulatory effects in vitro, only placenta-derived (PD-MSCs) not evaluated an vivo model GVHD. In this study, we investigated PD-MSCs vitro and their clinical potential for controlling GVHD animal model.A was established by transplanting C57BL/6 donor bone marrow spleen...

10.1159/000345267 article EN Acta Haematologica 2012-12-21

Pre-engraftment syndrome (PES) is poorly characterized, and its clinical significance the prognostic impact after unrelated cord blood transplantation (CBT) are unclear. To address these issues, we retrospectively analyzed incidence, risk factors, outcomes of PES in CBT recipients. Data 381 patients who received from 18 medical centers Korea were reviewed. was defined as unexplained fever >38.3°C not associated with infection, and/or skin rash or without evidence fluid retention before...

10.1016/j.bbmt.2013.01.014 article EN cc-by-nc-nd Biology of Blood and Marrow Transplantation 2013-02-01

Vascular endothelial growth factor (VEGF) and its receptor kinase insert domain-containing (KDR) play crucial roles in angiogenesis, which contributes to the development progression of solid tumors. The aim this study was investigate associations VEGF (-2578C > A, -1154G -634G C, 936C T) KDR (-604T C 1192G A) polymorphisms with colorectal cancer (CRC). A total 882 participants (390 CRC patients 492 controls) were enrolled study. genotyping performed by polymerase chain reaction-restriction...

10.1002/mc.21980 article EN Molecular Carcinogenesis 2012-11-20

Korean Guidelines for the Prevention of Venous ThromboembolismThis guideline focuses on primary prevention venous thromboembolism (VTE) in Korea.The guidelines should be individualized and aim at patients scheduled major surgery, as well with a history trauma, high-risk pregnancy, cancer, or other severe medical illnesses.Currently, no nation-wide data incidence VTE exist, randomized controlled trials aiming Korea have yielded few results.Therefore, these were based second edition Japanese...

10.3346/jkms.2010.25.11.1553 article EN cc-by-nc Journal of Korean Medical Science 2010-01-01

Folate has essential roles in DNA synthesis, repair and methylation. metabolism-related gene variants may modulate the levels of this vitamin affect cancer risk. Thus, whether these polymorphisms play an important role carcinogenesis, particularly colorectal (CRC) development, been a subject interest. The present study investigated association between methylenetetrahydrofolate reductase (MTHFR), thymidylate synthase (TS) reduced folate carrier 1 (RFC1) genes CRC Polymorphisms MTHFR (677C>T...

10.3892/mco.2015.520 article EN Molecular and Clinical Oncology 2015-02-27

MicroRNAs (miRNAs) are small 19- to 22-nucleotide sequences of RNA that participate in the regulation cell differentiation, cycle progression and apoptosis. Although single-nucleotide polymorphisms (SNPs) miRNA regions considered unlikely be functionally important, nucleotide variations within primary (pri)- or precursor (pre)-miRNAs may affect processing ultimately result modification expression. The aim this study was investigate associations between four SNPs pre-miRNA genes survival...

10.3892/etm.2011.321 article EN Experimental and Therapeutic Medicine 2011-01-01
Coming Soon ...